CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)

The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein-9 nuclease (Cas9) is a genome editing tool that has recently caught enormous attention due to its novelty, feasibility, and affordability. This system naturally functions as a defense mechanism in bacter...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruminis-Kaszkiel, Ewa, Juranek, Judyta, Maksymowicz, Wojciech, Wojtkiewicz, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877767/
https://www.ncbi.nlm.nih.gov/pubmed/29562705
http://dx.doi.org/10.3390/ijms19030906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877767/
https://www.ncbi.nlm.nih.gov/pubmed/29562705
http://dx.doi.org/10.3390/ijms19030906

Ejemplares similares